This company has been marked as potentially delisted and may not be actively trading. Kinnate Biopharma (KNTE) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock KNTE Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Kinetic Engineering Ltd (KNTE)July 24, 2024 | investing.comKNTE Kinnate Biopharma Inc.April 4, 2024 | seekingalpha.comKinnate Biopharma (Nasdaq:KNTE) HeadlineTrading was temporarily halted for "KNTE" at 07:04 PM with a stated reason of "News pending."...April 3, 2024 | marketbeat.comKinnate Biopharma Inc. (NASDAQ:KNTE) Receives Average Recommendation of "Hold" from AnalystsApril 1, 2024 | marketbeat.comKinnate Biopharma Inc. (NASDAQ:KNTE) Short Interest Down 43.6% in MarchMarch 28, 2024 | marketbeat.comCitigroup Inc. Increases Position in Kinnate Biopharma Inc. (NASDAQ:KNTE)March 22, 2024 | marketbeat.comKINNATE BIOPHARMA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kinnate Biopharma Inc. - KNTEMarch 13, 2024 | businesswire.comKinnate Biopharma (KNTE) to Release Quarterly Earnings on WednesdayMarch 12, 2024 | marketbeat.comKinnate Biopharma Inc. (NASDAQ:KNTE) Given Consensus Recommendation of "Hold" by BrokeragesMarch 7, 2024 | marketbeat.comKinnate Biopharma Inc. (NASDAQ:KNTE) Stake Increased by Citigroup Inc.March 4, 2024 | marketbeat.comKinnate Biopharma sells rights of exarafenib to Pierre Fabre laboratoriesMarch 1, 2024 | msn.comKinnate Biopharma Sells Exarafenib To Pierre Fabre Laboratories - Quick FactsMarch 1, 2024 | markets.businessinsider.comKinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre LaboratoriesMarch 1, 2024 | prnewswire.comKinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre LaboratoriesMarch 1, 2024 | globenewswire.comAcadian Asset Management LLC Raises Holdings in Kinnate Biopharma Inc. (NASDAQ:KNTE)February 29, 2024 | marketbeat.comStifel Nicolaus Boosts Kinnate Biopharma (NASDAQ:KNTE) Price Target to $2.59February 26, 2024 | marketbeat.comKINNATE BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kinnate Biopharma Inc. - KNTEFebruary 19, 2024 | businesswire.comKinnate Biopharma just downgraded at William Blair, here's whyFebruary 17, 2024 | realmoney.thestreet.comPrivate equity firms who hold 45% of Kinnate Biopharma Inc. (NASDAQ:KNTE) gained 11%, institutions profited as wellFebruary 17, 2024 | finance.yahoo.comALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kinnate Biopharma Inc.February 16, 2024 | prnewswire.comShareholder Alert: Ademi LLP investigates whether Kinnate Biopharma Inc. has obtained a Fair Price in its transaction with XOMAFebruary 16, 2024 | prnewswire.comKNTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Kinnate Biopharma Inc. Is Fair to ShareholdersFebruary 16, 2024 | businesswire.comKNTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Kinnate Biopharma Inc. Is Fair to ShareholdersFebruary 16, 2024 | businesswire.comKinnate Biopharma Inc. Enters into Agreement to be Acquired by XOMA Corporation for Between $2.3352 and $2.5879 Per Share in Cash, Plus One Contingent Value Right per ShareFebruary 16, 2024 | finance.yahoo.comKinnate Biopharma Inc. Enters into Agreement to be Acquired by XOMA Corporation for Between $2.3352 and $2.5879 Per Share in Cash, Plus One Contingent Value Right per ShareFebruary 16, 2024 | globenewswire.comKinnate Biopharma (Nasdaq:KNTE) HeadlineTrading was temporarily halted for "KNTE" at 07:02 AM with a stated reason of "News pending."...February 16, 2024 | marketbeat.comShort Interest in Kinnate Biopharma Inc. (NASDAQ:KNTE) Increases By 5.8%February 16, 2024 | marketbeat.comKinnate Biopharma Inc. (NASDAQ:KNTE) Receives Average Recommendation of "Hold" from BrokeragesFebruary 11, 2024 | marketbeat.comLeerink Partnrs Weighs in on Kinnate Biopharma Inc.'s Q3 2024 Earnings (NASDAQ:KNTE)February 8, 2024 | marketbeat.comLeerink Partnrs Comments on Kinnate Biopharma Inc.'s Q1 2024 Earnings (NASDAQ:KNTE)February 7, 2024 | marketbeat.comAnalysts Issue Forecasts for Kinnate Biopharma Inc.'s Q2 2024 Earnings (NASDAQ:KNTE)January 19, 2024 | marketbeat.comKinnate Biopharma Inc. (NASDAQ:KNTE) Forecasted to Earn Q1 2024 Earnings of ($0.41) Per ShareJanuary 18, 2024 | marketbeat.comWedbush Reiterates "Neutral" Rating for Kinnate Biopharma (NASDAQ:KNTE)January 17, 2024 | marketbeat.comKinnate Biopharma Inc. (NASDAQ:KNTE) Sees Large Growth in Short InterestJanuary 14, 2024 | marketbeat.comKinnate Biopharma: Righting The Ship, But Still Not The Right Time (Rating Upgrade)December 12, 2023 | seekingalpha.comKinnate Biopharma, Madrigal Pharma, and More Stocks See Action From Activist InvestorsNovember 24, 2023 | finance.yahoo.comWhy is Cancer-Focused Kinnate Biopharma Stock Trading Higher Today?November 15, 2023 | msn.comOrbiMed Advisors LLC Reduces Stake in Kinnate Biopharma IncNovember 15, 2023 | finance.yahoo.comKinnate Biopharma Inc. Reports Third Quarter 2023 Financial Results and Recent Corporate UpdatesNovember 9, 2023 | finance.yahoo.comInstrument Name Kinnate Biopharma Inc Instrument Symbol (KNTE-Q)October 4, 2023 | theglobeandmail.comKinnate Biopharma (KNTE) Falls 40% in a Month: Here's WhyOctober 3, 2023 | finance.yahoo.comJefferies Maintains Kinnate Biopharma (KNTE) Buy RecommendationSeptember 20, 2023 | msn.comBay Area biotech company Kinnate to lay off 70% of workforceSeptember 19, 2023 | msn.comWedbush Downgrades Kinnate Biopharma (KNTE)September 19, 2023 | msn.comWhy Is Cancer Firm Kinnate Biopharma Stock Trading Lower Today?September 19, 2023 | msn.comPiper Sandler Downgrades Kinnate Biopharma (KNTE)September 19, 2023 | msn.comAnalysts Move To Sidelines For Cancer Player Kinnate Biopharma After RestructuringSeptember 19, 2023 | markets.businessinsider.comKinnate slashes workforce by 70%, shelves three drug programsSeptember 18, 2023 | msn.comKinnate Biopharma Inc. Announces Pipeline Updates, Strategic Reprioritization and Workforce RestructuringSeptember 18, 2023 | finance.yahoo.comKinnate Biopharma (Nasdaq:KNTE) HeadlineTrading was temporarily halted for "KNTE" at 04:09 PM with a stated reason of "News pending."...September 18, 2023 | marketbeat.com Get Kinnate Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for KNTE and its competitors with MarketBeat's FREE daily newsletter. Email Address KNTE Media Mentions By Week KNTE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KNTE News Sentiment▼0.001.00▲Average Medical News Sentiment KNTE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KNTE Articles This Week▼00▲KNTE Articles Average Week Get Kinnate Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for KNTE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PHAXIAM Therapeutics News 60 Degrees Pharmaceuticals News Alpha Tau Medical News BriaCell Therapeutics News enGene News Fortress Biotech News GeoVax Labs News Jasper Therapeutics News Lexaria Bioscience News Nutriband News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KNTE) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kinnate Biopharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kinnate Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KNTE Stock Alerts